December 20, 2023
Please see attachment.
Contact information
Investor Relations
Disa Tuominen
+45 6038 5826
dkditu@chr-hansen.com
Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com
Attachment
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted
| Source: Chr. Hansen Holding A/S
Attachments
